(TM) Toyota Motor - Overview
Stock: Cars, Hybrids, Lexus, Buses, Finance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.53% |
| Yield on Cost 5y | 4.87% |
| Yield CAGR 5y | 9.19% |
| Payout Consistency | 95.0% |
| Payout Ratio | 10.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.8% |
| Relative Tail Risk | -3.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.93 |
| Alpha | 14.68 |
| Character TTM | |
|---|---|
| Beta | 0.925 |
| Beta Downside | 0.970 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.92% |
| CAGR/Max DD | 0.67 |
Description: TM Toyota Motor January 26, 2026
Toyota Motor Corporation (NYSE: TM) designs, manufactures, assembles, and sells a full spectrum of passenger, commercial, and specialty vehicles-including subcompact cars, SUVs, pickups, minivans, trucks, and buses-under the Toyota and Lexus brands, and it also develops battery-electric vehicles (BEVs) and related battery technology. Its operations span Automotive, Financial Services, and “All Other” segments, with ancillary activities such as the GAZOO.com automotive portal and limited telecommunications ventures.
In FY 2025 (ended March 2025), Toyota reported ¥33.5 trillion in revenue (≈ US$215 billion), a 6 % YoY increase driven largely by a 22 % rise in global BEV sales to 1.1 million units, and net income of ¥2.9 trillion, up 4 % year-over-year. The Financial Services segment contributed ¥1.2 trillion in profit, reflecting strong loan-to-value ratios amid stable interest-rate environments in its key markets.
Key macro drivers affecting Toyota include the gradual easing of semiconductor supply constraints, which has lifted production bottlenecks in North America and Europe, and tightening emissions regulations in China and the EU that are accelerating demand for hybrid and BEV models. Additionally, global consumer-credit conditions remain a material factor for the company’s financing business, with a 0.3 % rise in average auto-loan rates in the U.S. during Q4 2025.
For a deeper quantitative breakdown, see the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 4631.40b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 1.22 > 1.0 |
| NWC/Revenue: 16.02% < 20% (prev 13.78%; Δ 2.24% < -1%) |
| CFO/TA 0.05 > 3% & CFO 4824.37b > Net Income 4631.40b |
| Net Debt (31751.35b) to EBITDA (8470.75b): 3.75 < 3 |
| Current Ratio: 1.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.30b) vs 12m ago -1.96% < -2% |
| Gross Margin: 17.97% > 18% (prev 0.21%; Δ 1776 % > 0.5%) |
| Asset Turnover: 52.89% > 50% (prev 52.03%; Δ 0.86% > 0%) |
| Interest Coverage Ratio: 38.49 > 6 (EBITDA TTM 8470.75b / Interest Expense TTM 161.49b) |
Altman Z'' 2.95
| A: 0.08 (Total Current Assets 38942.72b - Total Current Liabilities 31031.19b) / Total Assets 97574.88b |
| B: 0.38 (Retained Earnings 37061.82b / Total Assets 97574.88b) |
| C: 0.07 (EBIT TTM 6216.07b / Avg Total Assets 93372.09b) |
| D: 0.70 (Book Value of Equity 41454.10b / Total Liabilities 59117.92b) |
| Altman-Z'' Score: 2.95 = A |
Beneish M -2.83
| DSRI: 1.02 (Receivables 15939.88b/14670.09b, Revenue 49385.01b/46396.16b) |
| GMI: 1.18 (GM 17.97% / 21.13%) |
| AQI: 0.96 (AQ_t 0.43 / AQ_t-1 0.45) |
| SGI: 1.06 (Revenue 49385.01b / 46396.16b) |
| TATA: -0.00 (NI 4631.40b - CFO 4824.37b) / TA 97574.88b) |
| Beneish M-Score: -2.83 (Cap -4..+1) = A |
What is the price of TM shares?
Over the past week, the price has changed by +7.65%, over one month by +13.45%, over three months by +20.34% and over the past year by +32.76%.
Is TM a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 245.7 | 0.6% |
| Analysts Target Price | 245.7 | 0.6% |
| ValueRay Target Price | 296 | 21.2% |
TM Fundamental Data Overview February 07, 2026
P/E Trailing = 10.4581
P/E Forward = 13.587
P/S = 0.0063
P/B = 1.3075
P/EG = 1.5387
Revenue TTM = 49385.01b JPY
EBIT TTM = 6216.07b JPY
EBITDA TTM = 8470.75b JPY
Long Term Debt = 23628.74b JPY (from longTermDebt, last quarter)
Short Term Debt = 16235.53b JPY (from shortTermDebt, last quarter)
Debt = 39864.28b JPY (from shortLongTermDebtTotal, last quarter)
Net Debt = 31751.35b JPY (from netDebt column, last quarter)
Enterprise Value = 80486.76b JPY (48735.40b + Debt 39864.28b - CCE 8112.92b)
Interest Coverage Ratio = 38.49 (Ebit TTM 6216.07b / Interest Expense TTM 161.49b)
EV/FCF = 544.6x (Enterprise Value 80486.76b / FCF TTM 147.79b)
FCF Yield = 0.18% (FCF TTM 147.79b / Enterprise Value 80486.76b)
FCF Margin = 0.30% (FCF TTM 147.79b / Revenue TTM 49385.01b)
Net Margin = 9.38% (Net Income TTM 4631.40b / Revenue TTM 49385.01b)
Gross Margin = 17.97% ((Revenue TTM 49385.01b - Cost of Revenue TTM 40509.25b) / Revenue TTM)
Gross Margin QoQ = 15.91% (prev 17.92%)
Tobins Q-Ratio = 0.82 (Enterprise Value 80486.76b / Total Assets 97574.88b)
Interest Expense / Debt = 0.05% (Interest Expense 18.80b / Debt 39864.28b)
Taxrate = 20.64% (253.03b / 1225.98b)
NOPAT = 4933.11b (EBIT 6216.07b * (1 - 20.64%))
Current Ratio = 1.25 (Total Current Assets 38942.72b / Total Current Liabilities 31031.19b)
Debt / Equity = 1.06 (Debt 39864.28b / totalStockholderEquity, last quarter 37492.12b)
Debt / EBITDA = 3.75 (Net Debt 31751.35b / EBITDA 8470.75b)
Debt / FCF = 214.8 (Net Debt 31751.35b / FCF TTM 147.79b)
Total Stockholder Equity = 36341.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.96% (Net Income 4631.40b / Total Assets 97574.88b)
RoE = 12.74% (Net Income TTM 4631.40b / Total Stockholder Equity 36341.85b)
RoCE = 10.37% (EBIT 6216.07b / Capital Employed (Equity 36341.85b + L.T.Debt 23628.74b))
RoIC = 6.54% (NOPAT 4933.11b / Invested Capital 75378.67b)
WACC = 5.15% (E(48735.40b)/V(88599.68b) * Re(9.33%) + D(39864.28b)/V(88599.68b) * Rd(0.05%) * (1-Tc(0.21)))
Discount Rate = 9.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.72%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈147.79b ; Y1≈182.30b ; Y5≈310.48b
Fair Price DCF = N/A (negative equity: EV 9041.10b - Net Debt 31751.35b = -22710.25b; debt exceeds intrinsic value)
EPS Correlation: 46.44 | EPS CAGR: -1.60% | SUE: -0.04 | # QB: 0
Revenue Correlation: 93.55 | Revenue CAGR: 13.16% | SUE: 0.01 | # QB: 0
EPS next Year (2027-03-31): EPS=20.61 | Chg30d=+0.220 | Revisions Net=-1 | Growth EPS=+24.4% | Growth Revenue=+4.0%